Literature DB >> 34192270

The role and uses of antibodies in COVID-19 infections: a living review.

D Oliver Scourfield1, Sophie G Reed1, Max Quastel2, Jennifer Alderson3, Valentina M T Bart1, Alicia Teijeira Crespo4, Ruth Jones5, Ellie Pring1, Felix Clemens Richter3, Stephanie E A Burnell1.   

Abstract

Coronavirus disease 2019 has generated a rapidly evolving field of research, with the global scientific community striving for solutions to the current pandemic. Characterizing humoral responses towards SARS-CoV-2, as well as closely related strains, will help determine whether antibodies are central to infection control, and aid the design of therapeutics and vaccine candidates. This review outlines the major aspects of SARS-CoV-2-specific antibody research to date, with a focus on the various prophylactic and therapeutic uses of antibodies to alleviate disease in addition to the potential of cross-reactive therapies and the implications of long-term immunity.
© The Author(s) 2021. Published by Oxford University Press.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; antibodies; convalescent plasma; long-term immunity; nanobodies; vaccines

Year:  2021        PMID： 34192270      PMCID： PMC7928637          DOI： 10.1093/oxfimm/iqab003

Source DB:  PubMed          Journal:  Oxf Open Immunol        ISSN： 2633-6960


  125 in total

1.  A pneumonia outbreak associated with a new coronavirus of probable bat origin.

Authors:  Peng Zhou; Xing-Lou Yang; Xian-Guang Wang; Ben Hu; Lei Zhang; Wei Zhang; Hao-Rui Si; Yan Zhu; Bei Li; Chao-Lin Huang; Hui-Dong Chen; Jing Chen; Yun Luo; Hua Guo; Ren-Di Jiang; Mei-Qin Liu; Ying Chen; Xu-Rui Shen; Xi Wang; Xiao-Shuang Zheng; Kai Zhao; Quan-Jiao Chen; Fei Deng; Lin-Lin Liu; Bing Yan; Fa-Xian Zhan; Yan-Yi Wang; Geng-Fu Xiao; Zheng-Li Shi
Journal:  Nature       Date:  2020-02-03       Impact factor: 69.504

2.  Serology characteristics of SARS-CoV-2 infection after exposure and post-symptom onset.

Authors:  Bin Lou; Ting-Dong Li; Shu-Fa Zheng; Ying-Ying Su; Zhi-Yong Li; Wei Liu; Fei Yu; Sheng-Xiang Ge; Qian-Da Zou; Quan Yuan; Sha Lin; Cong-Ming Hong; Xiang-Yang Yao; Xue-Jie Zhang; Ding-Hui Wu; Guo-Liang Zhou; Wang-Heng Hou; Ting-Ting Li; Ya-Li Zhang; Shi-Yin Zhang; Jian Fan; Jun Zhang; Ning-Shao Xia; Yu Chen
Journal:  Eur Respir J       Date:  2020-08-27       Impact factor: 16.671

3.  A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia.

Authors:  Ventura A Simonovich; Leandro D Burgos Pratx; Paula Scibona; María V Beruto; Marcelo G Vallone; Carolina Vázquez; Nadia Savoy; Diego H Giunta; Lucía G Pérez; Marisa Del L Sánchez; Andrea Vanesa Gamarnik; Diego S Ojeda; Diego M Santoro; Pablo J Camino; Sebastian Antelo; Karina Rainero; Gabriela P Vidiella; Erica A Miyazaki; Wanda Cornistein; Omar A Trabadelo; Fernando M Ross; Mariano Spotti; Gabriel Funtowicz; Walter E Scordo; Marcelo H Losso; Inés Ferniot; Pablo E Pardo; Eulalia Rodriguez; Pablo Rucci; Julieta Pasquali; Nora A Fuentes; Mariano Esperatti; Gerardo A Speroni; Esteban C Nannini; Alejandra Matteaccio; Hernán G Michelangelo; Dean Follmann; H Clifford Lane; Waldo H Belloso
Journal:  N Engl J Med       Date:  2020-11-24       Impact factor: 91.245

4.  Proinflammatory IgG Fc structures in patients with severe COVID-19.

Authors:  Joseph Gonzalez; Karlie Edwards; Saborni Chakraborty; Vamsee Mallajosyula; Anthony S Buzzanco; Robert Sherwood; Cindy Buffone; Nimish Kathale; Susan Providenza; Markus M Xie; Jason R Andrews; Catherine A Blish; Upinder Singh; Haley Dugan; Patrick C Wilson; Tho D Pham; Scott D Boyd; Kari C Nadeau; Benjamin A Pinsky; Sheng Zhang; Matthew J Memoli; Jeffery K Taubenberger; Tasha Morales; Jeffrey M Schapiro; Gene S Tan; Prasanna Jagannathan; Taia T Wang
Journal:  Nat Immunol       Date:  2020-11-09       Impact factor: 25.606

5.  Duration of antibody responses after severe acute respiratory syndrome.

Authors:  Li-Ping Wu; Nai-Chang Wang; Yi-Hua Chang; Xiang-Yi Tian; Dan-Yu Na; Li-Yuan Zhang; Lei Zheng; Tao Lan; Lin-Fa Wang; Guo-Dong Liang
Journal:  Emerg Infect Dis       Date:  2007-10       Impact factor: 6.883

6.  Convalescent plasma is a clutch at straws in COVID-19 management! A systematic review and meta-analysis.

Authors:  Soumya Sarkar; Kapil D Soni; Puneet Khanna
Journal:  J Med Virol       Date:  2020-08-21       Impact factor: 20.693

7.  Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody.

Authors:  Xiaolong Tian; Cheng Li; Ailing Huang; Shuai Xia; Sicong Lu; Zhengli Shi; Lu Lu; Shibo Jiang; Zhenlin Yang; Yanling Wu; Tianlei Ying
Journal:  Emerg Microbes Infect       Date:  2020-02-17       Impact factor: 7.163

8.  Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019.

Authors:  Juanjuan Zhao; Quan Yuan; Haiyan Wang; Wei Liu; Xuejiao Liao; Yingying Su; Xin Wang; Jing Yuan; Tingdong Li; Jinxiu Li; Shen Qian; Congming Hong; Fuxiang Wang; Yingxia Liu; Zhaoqin Wang; Qing He; Zhiyong Li; Bin He; Tianying Zhang; Yang Fu; Shengxiang Ge; Lei Liu; Jun Zhang; Ningshao Xia; Zheng Zhang
Journal:  Clin Infect Dis       Date:  2020-11-19       Impact factor: 9.079

9.  Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail.

Authors:  Johanna Hansen; Alina Baum; Kristen E Pascal; Vincenzo Russo; Stephanie Giordano; Elzbieta Wloga; Benjamin O Fulton; Ying Yan; Katrina Koon; Krunal Patel; Kyung Min Chung; Aynur Hermann; Erica Ullman; Jonathan Cruz; Ashique Rafique; Tammy Huang; Jeanette Fairhurst; Christen Libertiny; Marine Malbec; Wen-Yi Lee; Richard Welsh; Glen Farr; Seth Pennington; Dipali Deshpande; Jemmie Cheng; Anke Watty; Pascal Bouffard; Robert Babb; Natasha Levenkova; Calvin Chen; Bojie Zhang; Annabel Romero Hernandez; Kei Saotome; Yi Zhou; Matthew Franklin; Sumathi Sivapalasingam; David Chien Lye; Stuart Weston; James Logue; Robert Haupt; Matthew Frieman; Gang Chen; William Olson; Andrew J Murphy; Neil Stahl; George D Yancopoulos; Christos A Kyratsous
Journal:  Science       Date:  2020-06-15       Impact factor: 47.728

10.  Distinct features of SARS-CoV-2-specific IgA response in COVID-19 patients.

Authors:  Hai-Qiong Yu; Bao-Qing Sun; Zhang-Fu Fang; Jin-Cun Zhao; Xiao-Yu Liu; Yi-Min Li; Xi-Zhuo Sun; Hong-Feng Liang; Bei Zhong; Zhi-Feng Huang; Pei-Yan Zheng; Li-Feng Tian; Hui-Qi Qu; De-Chen Liu; Er-Yi Wang; Xiao-Jun Xiao; Shi-Yue Li; Feng Ye; Li Guan; Dong-Sheng Hu; Hakon Hakonarson; Zhi-Gang Liu; Nan-Shan Zhong
Journal:  Eur Respir J       Date:  2020-08-27       Impact factor: 16.671
View more
  9 in total

1.  Detection of Neutralizing Antibodies against SARS-CoV-2 Post-Vaccination in Health Care Workers of a Large Tertiary Hospital in Spain by Using a Rapid Test LFIC and sVNT-ELISA.

Authors:  José Tuells; Mónica Parra-Grande; Francisco J Santos-Calle; Ana C Montagud; Cecilia M Egoavil; Celia García-Rivera; Pablo Caballero; Eva M Gabaldón-Bravo; Juan Carlos Rodríguez-Diaz; José Antonio Hurtado-Sánchez
Journal:  Vaccines (Basel)       Date:  2022-03-25

2.  Communication pathways bridge local and global conformations in an IgG4 antibody.

Authors:  Thomas Tarenzi; Marta Rigoli; Raffaello Potestio
Journal:  Sci Rep       Date:  2021-12-01       Impact factor: 4.379

3.  Electrochemical Immunoassay for the Detection of SARS-CoV-2 Nucleocapsid Protein in Nasopharyngeal Samples.

Authors:  Isabelle C Samper; Catherine J McMahon; Melissa S Schenkel; Kaylee M Clark; Wisarut Khamcharoen; Loran B R Anderson; James S Terry; Emily N Gallichotte; Gregory D Ebel; Brian J Geiss; David S Dandy; Charles S Henry
Journal:  Anal Chem       Date:  2022-03-09       Impact factor: 6.986

Review 4.  The SARS-CoV-2 Antibodies, Their Diagnostic Utility, and Their Potential for Vaccine Development.

Authors:  Khalid Hajissa; Ali Mussa; Mohmed Isaqali Karobari; Muhammad Adamu Abbas; Ibrahim Khider Ibrahim; Ali A Assiry; Azhar Iqbal; Saad Alhumaid; Abbas Al Mutair; Ali A Rabaan; Pietro Messina; Giuseppe Alessandro Scardina
Journal:  Vaccines (Basel)       Date:  2022-08-18

5.  Enhanced SARS-CoV-2 IgG durability following COVID-19 mRNA booster vaccination and comparison of BNT162b2 with mRNA-1273.

Authors:  Samuel M Ailsworth; Behnam Keshavarz; Nathan E Richards; Lisa J Workman; Deborah D Murphy; Michael R Nelson; Thomas A E Platts-Mills; Jeffrey M Wilson
Journal:  Ann Allergy Asthma Immunol       Date:  2022-10-11       Impact factor: 6.248

6.  COVID-19 patients exhibit unique transcriptional signatures indicative of disease severity.

Authors:  Andrea R Daamen; Prathyusha Bachali; Catherine A Bonham; Lindsay Somerville; Jeffrey M Sturek; Amrie C Grammer; Alexandra Kadl; Peter E Lipsky
Journal:  Front Immunol       Date:  2022-09-15       Impact factor: 8.786

7.  Circulating IgG Levels in SARS-CoV-2 Convalescent Individuals in Cyprus.

Authors:  Ioannis Mamais; Apostolos Malatras; Gregory Papagregoriou; Natasa Giallourou; Andrea C Kakouri; Peter Karayiannis; Maria Koliou; Eirini Christaki; Georgios K Nikolopoulos; Constantinos Deltas
Journal:  J Clin Med       Date:  2021-12-15       Impact factor: 4.241

8.  Endogenous Antibody Responses to SARS-CoV-2 in Patients With Mild or Moderate COVID-19 Who Received Bamlanivimab Alone or Bamlanivimab and Etesevimab Together.

Authors:  Lin Zhang; Josh Poorbaugh; Michael Dougan; Peter Chen; Robert L Gottlieb; Gregory Huhn; Stephanie Beasley; Montanea Daniels; Thi Ngoc Vy Trinh; Melissa Crisp; Joshua Joaquin Freitas; Peter Vaillancourt; Dipak R Patel; Ajay Nirula; Nicole L Kallewaard; Richard E Higgs; Robert J Benschop
Journal:  Front Immunol       Date:  2021-12-09       Impact factor: 7.561

9.  COVID-19: Failure of the DisCoVeRy Clinical Trial, and Now-New Hopes?

Authors:  Jean Jacques Vanden Eynde
Journal:  Pharmaceuticals (Basel)       Date:  2021-07-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.